These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 31019610)

  • 1. Differentiation between non-hypervascular pancreatic neuroendocrine tumour and pancreatic ductal adenocarcinoma on dynamic computed tomography and non-enhanced magnetic resonance imaging.
    Ohki K; Igarashi T; Ashida H; Shiraishi M; Nozawa Y; Ojiri H
    Pol J Radiol; 2019; 84():e153-e161. PubMed ID: 31019610
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nonhypervascular pancreatic neuroendocrine tumors: Spectrum of MDCT imaging findings and differentiation from pancreatic ductal adenocarcinoma.
    Karmazanovsky G; Belousova E; Schima W; Glotov A; Kalinin D; Kriger A
    Eur J Radiol; 2019 Jan; 110():66-73. PubMed ID: 30599875
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pancreatic neuroendocrine tumour (PNET): Staging accuracy of MDCT and its diagnostic performance for the differentiation of PNET with uncommon CT findings from pancreatic adenocarcinoma.
    Kim JH; Eun HW; Kim YJ; Lee JM; Han JK; Choi BI
    Eur Radiol; 2016 May; 26(5):1338-47. PubMed ID: 26253257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CT and MR imaging features of mixed neuroendocrine-non-neuroendocrine neoplasm of the pancreas compared with pancreatic ductal adenocarcinoma and neuroendocrine tumor.
    Zhong Y; Zhang H; Wang X; Sun Z; Ge Y; Dou W; Hu S
    Insights Imaging; 2023 Jan; 14(1):15. PubMed ID: 36690735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The differentiation of pancreatic neuroendocrine carcinoma from pancreatic ductal adenocarcinoma: the values of CT imaging features and texture analysis.
    Guo C; Zhuge X; Wang Q; Xiao W; Wang Z; Wang Z; Feng Z; Chen X
    Cancer Imaging; 2018 Oct; 18(1):37. PubMed ID: 30333055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differentiation between non-hypervascular pancreatic neuroendocrine tumors and mass-forming pancreatitis using contrast-enhanced computed tomography.
    Wang Y; Chen X; Wang J; Cui W; Wang C; Chen X; Wang Z
    Acta Radiol; 2021 Feb; 62(2):190-197. PubMed ID: 32375515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Qualitative and quantitative imaging features of solid pancreas tumours in portal venous phase CT: are they useful in determining tumour type and grade?
    Gündoğdu E; Küçükhüseyin A
    Pol J Radiol; 2024; 89():e140-e147. PubMed ID: 38550958
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MRI Feature-Based Nomogram Model for Discrimination Between Non-Hypervascular Pancreatic Neuroendocrine Tumors and Pancreatic Ductal Adenocarcinomas.
    Xu J; Yang J; Feng Y; Zhang J; Zhang Y; Chang S; Jin J; Du X
    Front Oncol; 2022; 12():856306. PubMed ID: 35664797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Whole-tumor histogram analysis of non-Gaussian distribution DWI parameters to differentiation of pancreatic neuroendocrine tumors from pancreatic ductal adenocarcinomas.
    Li J; Liang L; Yu H; Shen Y; Hu Y; Hu D; Tang H; Li Z
    Magn Reson Imaging; 2019 Jan; 55():52-59. PubMed ID: 30240758
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differentiation between pancreatic metastases from renal cell carcinoma and hypervascular neuroendocrine tumour: Use of relative percentage washout value and its clinical implication.
    Kang TW; Kim SH; Lee J; Kim AY; Jang KM; Choi D; Kim MJ
    Eur J Radiol; 2015 Nov; 84(11):2089-96. PubMed ID: 26318820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differentiation of pancreatic neuroendocrine carcinoma from pancreatic ductal adenocarcinoma using magnetic resonance imaging: The value of contrast-enhanced and diffusion weighted imaging.
    Guo C; Chen X; Wang Z; Xiao W; Wang Q; Sun K; Zhuge X
    Oncotarget; 2017 Jun; 8(26):42962-42973. PubMed ID: 28487490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dual-energy CT improves differentiation of non-hypervascular pancreatic neuroendocrine neoplasms from CA 19-9-negative pancreatic ductal adenocarcinomas.
    Hu X; Shi S; Wang Y; Yuan J; Chen M; Wei L; Deng W; Feng ST; Peng Z; Luo Y
    Radiol Med; 2024 Jan; 129(1):1-13. PubMed ID: 37861978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Computed tomography in determining the differentiation of ductal adenocarcinoma of pancreatic head].
    Shantarevich MY; Karmazanovsky GG; Egorkina AB; Kurochkina AI; Kriger AG; Kalinin DV; Stashkiv VI
    Khirurgiia (Mosk); 2021; (3):11-19. PubMed ID: 33710821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interobserver Variability and Accuracy of Preoperative CT and MRI in Pancreatic Ductal Adenocarcinoma Size Estimation: A Retrospective Cohort Study.
    Cocquempot R; Bonnin A; Barat M; Naveendran G; Dohan A; Fuks D; Terris B; Coriat R; Hoeffel C; Marchese U; Soyer P
    Can Assoc Radiol J; 2023 Aug; 74(3):570-581. PubMed ID: 36347588
    [No Abstract]   [Full Text] [Related]  

  • 15. DPC4 gene expression in primary pancreatic ductal adenocarcinoma: relationship with CT characteristics.
    Choi SH; Kim HJ; Kim KW; An S; Hong SM; Kim SC; Kim MH
    Br J Radiol; 2017 May; 90(1073):20160403. PubMed ID: 28339284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypervascular solid-appearing serous cystic neoplasms of the pancreas: Differential diagnosis with neuroendocrine tumours.
    Park HS; Kim SY; Hong SM; Park SH; Lee SS; Byun JH; Kim JH; Kim HJ; Lee MG
    Eur Radiol; 2016 May; 26(5):1348-58. PubMed ID: 26328927
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of ring-enhancement and focal necrosis to differentiate pancreatic adenosquamous carcinoma from pancreatic ductal adenocarcinoma on CT and MRI.
    Schawkat K; Tsai LL; Jaramillo-Cardoso A; Paez SN; Moser JA; Decicco C; Singer T; Glickman J; Brook A; Manning MA; Mortele KJ
    Clin Imaging; 2021 May; 73():134-138. PubMed ID: 33387918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Magnetic Resonance Imaging May Be Able to Identify the Origin of Neuroendocrine Tumor Liver Metastases.
    Barat M; Soyer P; Al Sharhan F; Terris B; Oudjit A; Gaujoux S; Coriat R; Hoeffel C; Dohan A
    Neuroendocrinology; 2021; 111(11):1099-1110. PubMed ID: 33190136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Usefulness of non-contrast MR imaging in distinguishing pancreatic ductal adenocarcinoma from focal pancreatitis.
    Lee JH; Min JH; Kim YK; Cha DI; Lee J; Park HJ; Ahn S
    Clin Imaging; 2019; 55():132-139. PubMed ID: 30818163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differentiation of atypical pancreatic neuroendocrine tumors from pancreatic ductal adenocarcinomas: Using whole-tumor CT texture analysis as quantitative biomarkers.
    Li J; Lu J; Liang P; Li A; Hu Y; Shen Y; Hu D; Li Z
    Cancer Med; 2018 Oct; 7(10):4924-4931. PubMed ID: 30151864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.